These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3768017)

  • 1. Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat.
    Simpson MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1986 Oct; 35(19):3203-8. PubMed ID: 3768017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P; Rupniak NM; Marsden CD
    Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.
    Simpson MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1986 Oct; 35(20):3501-6. PubMed ID: 3768037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG; Sinha YN; Finch CE
    Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity.
    Rupniak N; Hong M; Mansfield S; Fleminger S; Dyer R; Jenner P; Marsden CD
    Eur J Pharmacol; 1983 Sep; 93(3-4):195-200. PubMed ID: 6139285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic sulpiride on striatal spiperone binding.
    Bannet J; Gillis S; Ebstein RP; Belmaker RH
    Int Pharmacopsychiatry; 1980; 15(6):334-7. PubMed ID: 7298264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors.
    Di Paolo T; Daigle M; Labrie F
    Psychoneuroendocrinology; 1984; 9(4):399-404. PubMed ID: 6514934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
    Cronin MJ; Reches A; MacLeod RM; Login IS
    Eur J Pharmacol; 1983 Jul; 91(2-3):229-34. PubMed ID: 6617744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
    Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbits.
    Eva C; Blengio M; Ferretti C; Muccioli G; Portaleone P
    Brain Res; 1982 Nov; 251(2):388-90. PubMed ID: 7139336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor binding sites in the rat superior colliculus.
    Chivers JK; Hall MD; Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1984 Jul; 36(7):484-8. PubMed ID: 6146700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin and estradiol increase striatal dopamine receptor density in intact, castrated and hypophysectomized rats.
    Di Paolo T; Poyet P; Labrie F
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):377-82. PubMed ID: 6891804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
    Tecott LH; Kwong LL; Uhr S; Peroutka SJ
    Biol Psychiatry; 1986 Oct; 21(12):1114-22. PubMed ID: 2428411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neuroleptic binding characteristics in rat striatum and renal cortex.
    Hietala J; Syvälahti E; Röyttä M
    J Recept Res; 1988; 8(6):753-71. PubMed ID: 3193400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.